29 September 2021
Hogan Lovells advises Eli Lilly and Company on the conclusion of a framework agreement with the EU Commission for COVID-19 treatment
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Ciara Kennedy-Loest Lead | Hogan Lovells Cadwalader | Partner | Competition, Public & EU Law | London |
| Arne Thiermann Lead | Hogan Lovells Cadwalader | Partner | Strategic Operations, Agreements and Regulation (SOAR) – Life Sciences | Hamburg |
| Fabien Roy | Hogan Lovells Cadwalader | Partner | Medical Device and Technology | Brussels |
| Dr. Benjamin Göhl | Hogan Lovells Cadwalader | Associate | Strategic Operations, Agreements and Regulation (SOAR) – Life Sciences | Munich |
| Katharina Kranzfelder | Hogan Lovells Cadwalader | Senior associate | Business Restructuring and Insolvency | Munich |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Eli Lilly and CompanyOther
- Counterparties
- European Commission (Other)